COMMUNIQUÉS West-GlobeNewswire

Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial
19/04/2024
EDISON, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic steatohepatitis (“NASH”), [...]
Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock
19/04/2024
CAPE CANAVERAL, Fla., April 19, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (“Vaxxinity”, “we”, “us” or the “Company”) (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of medicines, today announced [...]
Correction to Company announcement – No. 23 / 2024
19/04/2024
Correction to Company announcement – No. 23 / 2024 Copenhagen, Denmark, April 19, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the [...]
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19/04/2024
REDWOOD CITY, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]
Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024
19/04/2024
UPPSALA, Sweden, April 19, 2024 (GLOBE NEWSWIRE) -- At the Annual General Meeting (the “AGM”) of Olink Holding AB (publ), reg. no 559189-7755, (the “Company”), on 19 April 2024 the AGM adopted, inter alia, the following [...]
NurExone Presenting on Revolutionary Spinal Cord Injury Therapy at European Conference on Exosomes and Regenerative Medicine
19/04/2024
TORONTO and HAIFA, Israel, April 19, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, is pleased to announce that Dr. Lior [...]
Vision Sensing Acquisition Corp. Receives Positive Ruling from Nasdaq Hearings Panel
19/04/2024
NEW YORK, April 19, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “ Company ” or “ VSAC ”), a special purpose acquisition company, issues an update regarding the previously [...]
Retrieve Medical Advances Healthcare Documentation in Louisiana with New Software Implementation
19/04/2024
BEDMINSTER, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- Retrieve Medical Holdings, Inc. (OTC Pink: RMHI) is pleased to announce that its wholly owned subsidiary, Retrieve Medical, Inc., has successfully launched its [...]
UPDATE - New Study Reveals Potential Treatment for Neurological Lyme Disease
19/04/2024
Blocking certain fibroblast growth factor receptors is shown to be effective in reducing inflammation and cell death caused by neurological Lyme infection in laboratory studies PORTOLA VALLEY, Calif., April 19, 2024 ( [...]
Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025
19/04/2024
NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR IN OR INTO AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. Leiden, the Netherlands [...]
Carbios files its 2023 Universal Registration Document
19/04/2024
Clermont-Ferrand, France, 19 April 2024 (18.30 CEST). Carbios (Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastics and [...]
Carbios annonce la mise à disposition de son Document d’enregistrement universel 2023
19/04/2024
Clermont-Ferrand, France, 19 avril 2024 (18h30 CEST). Carbios (Euronext Growth Paris : ALCRB), pionnier dans le développement et l'industrialisation de technologies biologiques pour réinventer le cycle de vie des [...]
Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
19/04/2024
HOUSTON, April 19, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (Nasdaq: BPTH) (the “Company” or “Bio-Path”), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to [...]
St. Vincent Regional Hospital Verified as Level I Trauma Center by American College of Surgeons
19/04/2024
Billings, Montana, April 19, 2024 (GLOBE NEWSWIRE) -- Intermountain Health St. Vincent Regional Hospital is proud to announce its official verification as a Level I Trauma Center by the American College of Surgeons (ACS [...]
LeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024
19/04/2024
BURLINGTON, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2024 financial results on Thursday, May 2, 2024, after the market close [...]
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
19/04/2024
Company announcement – No. 23 / 2024 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, April [...]
Zealand Pharma launches long-term incentive programs for Zealand’s Board of Directors, Corporate Management and employees for 2024
19/04/2024
Company announcement – No. 22 / 2024 Zealand Pharma launches long-term incentive programs for Zealand’s Board of Directors, Corporate Management and employees for 2024 Copenhagen, Denmark, April 19, 2024 – Zealand [...]
Dr. Sam Barrell CBE appointed as CEO of LifeArc
19/04/2024
PRESS RELEASE FOR IMMEDIATE PUBLICATION 19 April 2024 Dr. Sam Barrell CBE appointed as CEO of LifeArc LifeArc is pleased to announce the appointment of Dr. Sam Barrell, CBE, as Chief Executive Officer. Sam’s appointment [...]
TScan Therapeutics Announces Closing of Upsized Public Offering
19/04/2024
WALTHAM, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR [...]

Pages